US 8471040
Serotonin reuptake inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8471040 (Serotonin reuptake inhibitors) held by Theravance, Inc. expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/00, A61P19/02